| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.08 | 0.6 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |